{ "cik": 1517022, "cik_padded": "0001517022", "entityName": "Akebia Therapeutics, Inc.", "fiscal_years": [ { "accn": "0001517022-26-000020", "filed": "2026-02-26", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 291000.0, "cash": 184844000.0, "eps_diluted": -0.02, "free_cash_flow": 67701000.0, "net_income": -5345000.0, "operating_cash_flow": 67992000.0, "operating_income": 23499000.0, "revenue": 236196000.0, "stockholders_equity": 32610000.0, "total_assets": 376565000.0, "total_liabilities": 343955000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 10.54753143207605, "net_margin": -0.022629511084014967, "operating_margin": 0.09948940710257582, "revenue_growth_yoy": 0.47456611312273694, "roa_avg2y": -0.017899151925121603, "roa_period_end": -0.014194096636702826, "roe_avg2y": 0.644947209653092, "roe_period_end": -0.16390677706225085 } }, { "accn": "0001517022-26-000020", "filed": "2026-02-26", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 33000.0, "cash": 51870000.0, "eps_diluted": -0.33, "free_cash_flow": -40692000.0, "net_income": -69410000.0, "operating_cash_flow": -40659000.0, "operating_income": -50472000.0, "revenue": 160180000.0, "stockholders_equity": -49185000.0, "total_assets": 220670000.0, "total_liabilities": 269855000.0 }, "period_end": "2024-12-31", "ratio_units": { "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "net_margin": -0.433325009364465, "operating_margin": -0.3150955175427644, "revenue_growth_yoy": -0.17697291687005132, "roa_avg2y": -0.3002337939282787, "roa_period_end": -0.3145420764036797, "roe_avg2y": 1.740275044190099 } }, { "accn": "0001517022-26-000020", "filed": "2026-02-26", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 0.0, "cash": 42925000.0, "eps_diluted": -0.28, "free_cash_flow": -23384000.0, "net_income": -51925000.0, "operating_cash_flow": -23384000.0, "operating_income": -46256000.0, "revenue": 194623000.0, "stockholders_equity": -30584000.0, "total_assets": 241703000.0, "total_liabilities": 272287000.0 }, "period_end": "2023-12-31", "ratio_units": { "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "net_margin": -0.2667978604789773, "operating_margin": -0.23766975126269763, "revenue_growth_yoy": -0.3345858234980375, "roa_avg2y": -0.17373280446736716, "roa_period_end": -0.21482977042072296, "roe_avg2y": 4.096000631064132 } }, { "accn": "0001628280-24-011270", "filed": "2026-02-26", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 114000.0, "cash": 90466000.0, "eps_diluted": -0.52, "free_cash_flow": -73268000.0, "net_income": -94226000.0, "operating_cash_flow": -73154000.0, "operating_income": -80779000.0, "revenue": 292484000.0, "stockholders_equity": 5230000.0, "total_assets": 356054000.0, "total_liabilities": 350824000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "leverage": 67.0791586998088, "net_margin": -0.3221577932468101, "operating_margin": -0.2761826287933699, "revenue_growth_yoy": 0.3819229860618946, "roa_avg2y": -0.2128436719633251, "roa_period_end": -0.2646396333140479, "roe_avg2y": -2.3783033393068984 } }, { "accn": "0001628280-24-011270", "filed": "2024-03-14", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 59000.0, "cash": 149800000.0, "eps_diluted": -1.7, "free_cash_flow": -253024000.0, "net_income": -282024000.0, "operating_cash_flow": -252965000.0, "operating_income": -264502000.0, "revenue": 211650000.0, "stockholders_equity": 74008000.0, "total_assets": 529347000.0, "total_liabilities": 455339000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 6.15256458761215, "net_margin": -1.3325017717930543, "operating_margin": -1.2497141507205292, "revenue_growth_yoy": -0.28167551350103853, "roa_avg2y": -0.48066018682796385, "roa_period_end": -0.5327771764079139, "roe_avg2y": -1.7717189865624667, "roe_period_end": -3.810723165063236 } }, { "accn": "0001628280-23-030697", "filed": "2023-08-28", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 317000.0, "cash": 228698000.0, "eps_diluted": -2.78, "free_cash_flow": -110705000.0, "net_income": -384841000.0, "operating_cash_flow": -110388000.0, "operating_income": -377826000.0, "revenue": 294644000.0, "stockholders_equity": 244354000.0, "total_assets": 644139000.0, "total_liabilities": 396521000.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.622731774392889, "net_margin": -1.3061219641329875, "operating_margin": -1.2823135716322072, "revenue_growth_yoy": -0.12046829710956086, "roa_avg2y": -0.5438142071869657, "roa_period_end": -0.5974502397774394, "roe_avg2y": -1.2078539807385391, "roe_period_end": -1.5749322703945914 } }, { "accn": "0001628280-23-030697", "filed": "2023-08-28", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 6655000.0, "cash": 147449000.0, "eps_diluted": -2.36, "free_cash_flow": -264096000.0, "net_income": -279659000.0, "operating_cash_flow": -257441000.0, "operating_income": -286288000.0, "revenue": 335001000.0, "stockholders_equity": 392877000.0, "total_assets": 771201000.0, "total_liabilities": 376444000.0 }, "period_end": "2019-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.9581726596364766, "net_margin": -0.8348004931328563, "operating_margin": -0.8545884937656902, "revenue_growth_yoy": 0.6125819526143005, "roa_avg2y": -0.31640268568755264, "roa_period_end": -0.36262790115676713, "roe_avg2y": -0.5436579332332172, "roe_period_end": -0.7118232932953571 } }, { "accn": "0001628280-22-004522", "filed": "2022-03-01", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1606000.0, "cash": 104644000.0, "free_cash_flow": -99100000.0, "net_income": -143588000.0, "operating_cash_flow": -97494000.0, "operating_income": -178161000.0, "revenue": 207742000.0, "stockholders_equity": 635928000.0, "total_assets": 996540000.0, "total_liabilities": 360612000.0 }, "period_end": "2018-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.567064195946711, "net_margin": -0.6911842573961934, "operating_margin": -0.8576070317990585, "revenue_growth_yoy": 0.14630822118117057, "roa_avg2y": -0.21103670155579088, "roa_period_end": -0.1440865394264154, "roe_avg2y": -0.3786094169824206, "roe_period_end": -0.2257928570529997 } }, { "accn": "0001628280-21-003283", "filed": "2021-02-25", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1622000.0, "cash": 70156000.0, "free_cash_flow": -57781000.0, "net_income": -73671000.0, "operating_cash_flow": -56159000.0, "operating_income": -76674000.0, "revenue": 181227000.0, "stockholders_equity": 122574000.0, "total_assets": 364247000.0, "total_liabilities": 241673000.0 }, "period_end": "2017-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.9716497789090672, "net_margin": -0.40651227466106044, "operating_margin": -0.4230826532470327, "revenue_growth_yoy": 117.06319218241042, "roa_avg2y": -0.22174598134132376, "roa_period_end": -0.20225561226310718, "roe_avg2y": -0.7726619610475421, "roe_period_end": -0.6010328454647804 } }, { "accn": "0001564590-20-010491", "filed": "2020-03-12", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 2662000.0, "cash": 187335000.0, "free_cash_flow": 55244000.0, "net_income": -135747000.0, "operating_cash_flow": 57906000.0, "operating_income": -136460000.0, "revenue": 1535000.0, "stockholders_equity": 68120000.0, "total_assets": 300216000.0, "total_liabilities": 232096000.0 }, "period_end": "2016-12-31", "ratio_units": { "leverage": "ratio", "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 3.4071638285378745, "roa_period_end": -0.4521644416020465, "roe_period_end": -1.9927627715795655 } } ], "latest_filing": { "accn": "0001517022-26-000020", "filed": "2026-02-26", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001517022.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001517022.json" }, "ticker": "AKBA" }